Other languages Repligen Corporation

Equities

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
165.7 ^USD	-1.31%		+5.48%	-7.86%

Apr. 08	RBC Cuts Price Target on Repligen to $221 From $225, Keeps Outperform Rating	MT
Mar. 20	Transcript : Repligen Corporation Presents at KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum, Mar-20-2024 03:00 PM

Repligen Corporation Appoints Maggie A. Pax as Board of Directors	Mar. 19
Repligen Insider Sold Shares Worth $681,348, According to a Recent SEC Filing	Mar. 13
Repligen Insider Sold Shares Worth $3,298,632, According to a Recent SEC Filing	Mar. 12
Repligen Insider Sold Shares Worth $866,204, According to a Recent SEC Filing	Feb. 27
Aktien Frankfurt Schluss: Dax stabil vor Zahlen des Trendsetters Nvidia	Feb. 21
Sector Update: Health Care Stocks Flat to Lower Premarket Wednesday	Feb. 21
Sector Update: Health Care	Feb. 21
Aktien Frankfurt: Dax-Rekordhoch vor Nvidia-Zahlen wieder in Sicht	Feb. 21
Repligen Q4 Adjusted Earnings, Revenue Decline; Issues 2024 Guidance; Shares Fall Premarket	Feb. 21
Sartorius fällt - Ausblick von Repligen enttäuscht	Feb. 21
Repligen Corporation Provides Earnings Guidance for the Year 2024	Feb. 21
Repligen Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 21
Repligen Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 21
Stocks Decline Pre-Bell as Fed Outlook, Rates Weigh; Asia Mixed, Europe Mostly Up	Feb. 21
Repligen to Seek Acquisitions	Dec. 07
Repligen Insider Sold Shares Worth $557,328, According to a Recent SEC Filing	Nov. 13
Repligen Corporation Launches TangenX®? SC as First-To-Market Holder-Free Self-Contained TFF Device	Nov. 02
MORNING BRIEFING - Deutschland/Europa	Nov. 01
Aktien Frankfurt Schluss: Inflation hilft Dax über 14 800 Punkte	23-10-31
Freundlich - Ende der Zinserhöhungen in Sicht	23-10-31

No results for this search